(Q37259375)

19 August 2017

Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea (English)

1 reference

19 August 2017

0 references

irritable bowel syndrome

1 reference

8

Alan R Zinsmeister

1 reference

19 August 2017

2

Michael Camilleri

1 reference

19 August 2017

1

Banny S Wong

1 reference

PMCID

3809827

Suwebatu T Odunsi-Shiyanbade

19 August 2017

series ordinal

4

object named as

Suwebatu Odunsi-Shiyanbade

1 reference

19 August 2017

5

Sanna McKinzie

1 reference

19 August 2017

7

Duane Burton

1 reference

19 August 2017

6

Irene Busciglio

1 reference

19 August 2017

Paula J Carlson

3

1 reference

PMCID

3809827

19 August 2017

language of work or name

1 reference

21 January 2012

1 reference

Digestive Diseases and Sciences

19 August 2017

1 reference

19 August 2017

57

1 reference

19 August 2017

5

1 reference

19 August 2017

1222-1226

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-012-2035-5

19 August 2017

0 references

cites work

A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3809827

Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3809827

Scintigraphic biomarkers for colonic dysmotility

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3809827

Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3809827

Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3809827

Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3809827

Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3809827

A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3809827

Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3809827

Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea

6 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3809827

6 September 2017

https://api.crossref.org/works/10.1007%2FS10620-012-2035-5

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3809827

Evaluation of ileal function using 23-selena-25-homotaurocholate, a-gamma-labeled conjugated bile acid. Initial clinical assessment

3 September 2018

1 reference

12 December 2020

Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes?

1 reference

12 December 2020

The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome

1 reference

12 December 2020

The prevalence of celiac disease in patients with irritable bowel syndrome

1 reference

12 December 2020

Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care

1 reference

12 December 2020

10.1007/S10620-012-2035-5

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

PMCID

3809827